Thaker PH, Richardson DL, Hagemann AR, Holloway RW, et al. OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer. Gynecol Oncol 2025 May 2:S0090-8258(25)00797.
PMID: 40461366